LifeStance Health Group, Inc.
LFST
$3.90
$0.010.26%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 16.31% | 18.50% | 20.08% | 20.56% | 21.39% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 16.31% | 18.50% | 20.08% | 20.56% | 21.39% |
| Cost of Revenue | 11.56% | 12.61% | 14.78% | 15.96% | 18.23% |
| Gross Profit | 27.58% | 33.20% | 33.68% | 32.57% | 29.63% |
| SG&A Expenses | 4.57% | 3.87% | 0.29% | 0.64% | -1.07% |
| Depreciation & Amortization | -25.96% | -11.79% | 1.80% | 10.13% | 15.64% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 6.93% | 8.38% | 9.49% | 10.79% | 11.73% |
| Operating Income | 88.81% | 76.42% | 63.05% | 48.52% | 38.36% |
| Income Before Tax | 79.71% | 72.11% | 60.78% | 14.27% | 6.42% |
| Income Tax Expenses | 82.97% | 99.16% | 124.21% | 60.34% | -9.60% |
| Earnings from Continuing Operations | 79.41% | 69.16% | 49.30% | 8.11% | 7.66% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 79.41% | 69.16% | 49.30% | 8.11% | 7.66% |
| EBIT | 88.81% | 76.42% | 63.05% | 48.52% | 38.36% |
| EBITDA | 307.20% | 190.39% | 135.05% | 102.07% | 76.49% |
| EPS Basic | 79.98% | 70.11% | 50.55% | 11.41% | 10.90% |
| Normalized Basic EPS | 73.11% | 62.91% | 55.58% | 43.63% | 36.14% |
| EPS Diluted | 80.14% | 69.34% | 49.80% | 10.56% | 10.16% |
| Normalized Diluted EPS | 73.11% | 62.91% | 55.58% | 43.63% | 36.14% |
| Average Basic Shares Outstanding | 2.98% | 3.59% | 3.56% | 4.09% | 3.64% |
| Average Diluted Shares Outstanding | 3.48% | 3.59% | 3.56% | 4.09% | 3.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |